-
Wells Fargo Upgrades ATHN To Outperform From Market Perform
Tuesday, February 8, 2011 - 9:44am | 25Wells Fargo is upgrading athenahealth, Inc. (NASDAQ: ATHN) to Outperform from Market Perform. Athenahealth closed Monday at $46.13.
-
Wells Fargo Upgrades ATHN To Outperform
Tuesday, February 8, 2011 - 6:46am | 41Analysts at Wells Fargo upgrade athenahealth Inc (NASDAQ: ATHN) from “market perform” to “outperform.” ATHN shares gained 3.08% to close at $46.13 yesterday. More Analyst Ratings here
-
Top 4 Large-Cap Stocks In The Drugs Wholesale Industry With The Lowest PEG Ratio (MHS, ABC, CAH, MCK)
Tuesday, February 8, 2011 - 5:46am | 118Below are the top large-cap drugs wholesale stocks on the NYSE and the NASDAQ, in terms of PEG ratio. MedcoHealth Solutions Inc (NYSE: MHS) has a PEG ratio of 1.11. MHS' trailing-twelve-month ROE is 26.20%. AmerisourceBergen Corporation (NYSE: ABC) has a PEG ratio of 1.16. ABC's trailing-twelve-...
-
IntegraMed to Host Q4 Conference Call Thursday, February 17th
Monday, February 7, 2011 - 1:06pm | 73IntegraMed America, Inc. (NASDAQ: INMD), the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that it will host an investment conference call and webcast to review its financial results for the fourth quarter ended...
-
Gabelli Morning Call (CNU, SXT, RIG, CLWR)
Monday, February 7, 2011 - 10:35am | 126Gabelli is out with its Morning Call, focusing on Continucare Corp. (NYSE: CNU), Sensient Technologies (NYSE: SXT), Transocean NYSE" RIG), and Clearwire (NASDAQ: CLWR). In the report, Gabelli reiterated its Continucare Corp Buy rating, left its Sensient Technologies Hold rating unchanged, reduced...
-
Jefferies Provides Color On DVA
Monday, February 7, 2011 - 9:52am | 169On the heels of a recent refinancing that netted DaVita Inc. (NYSE: DVA) $825MM in additional cash, management has earmarked $690MM of this capital to acquire DSI in a transaction valued at just over $86K/patient, Jefferies reports. “On an EBITDA basis, we estimate that the company is likely paying...
-
XDx and LabCorp Enter Into Expanded North American Agreement for XDx's AlloMap
Monday, February 7, 2011 - 9:06am | 114XDx, Inc today announced that it has entered into a multi-year agreement with Laboratory Corporation of America Holdings (NYSE: LH) to provide heart transplant patients eligible for XDx's AlloMap test with the convenience of having their blood drawn at participating LabCorp sites across the United...
-
Jefferies Raises PT On DaVita To $81
Monday, February 7, 2011 - 8:38am | 26Jefferies & Company has raised the price target on DaVita (NYSE: DVA) from $63 to $81 and maintains its Hold rating.
-
FTC Grants Genoptix Early Termination of Waiting Period
Monday, February 7, 2011 - 8:25am | 101Genoptix, Inc. (Nasdaq: GXDX) announced today that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended applicable to the cash tender offer by Novartis to purchase all outstanding shares of common...
-
DaVita to Acquire DSI Renal, Inc.
Friday, February 4, 2011 - 10:03am | 48DaVita Inc. (NYSE: DVA), announced that it has entered into a definitive agreement to acquire DSI Renal, Inc., for approximately $690 million, subject to adjustments. The company expects to close the transaction in the second or third quarter of this year.
-
Continucare Reports Q2 EPS of $0.10
Friday, February 4, 2011 - 8:16am | 55Continucare Corp (NYSE: CNU) reports its Q2 EPS at $0.10, versus the consensus of $0.10. CNU reports its Q2 revenue at $80.3 million, versus the consensus of $82.75 million. CNU shares fell 0.92% to close at $4.30 yesterday. Read more from Benzinga's Company news.
-
Deutsche Bank Raises The PT On Quest Diagnostics To $64 Following Buyback
Thursday, February 3, 2011 - 11:12am | 230Deutsche Bank considers Quest Diagnostics (NYSE: DGX) move to accelerate its buyback as a further sign of confidence. While it still believes better execution and more concrete signs of revenue growth will be the most important factors that could alter DB's fundamental Hold opinion on DGX shares,...
-
Zacks #5 Rank Additions for Thursday - Tale of the Tape
Thursday, February 3, 2011 - 9:31am | 344Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List today: Addus HomeCare Corp (ADUS) Amer Caresource Holdings (ANCI) Axcelis Tech Inc (ACLS) Carrizo Oil & Gas (CRZO) Carrols Restaurant Group (TAST) View the entire Zacks #5 Rank List. AXCELIS TECH (ACLS): Free Stock Analysis...
-
Zacks #5 Rank Additions for Thursday - Tale of the Tape
Thursday, February 3, 2011 - 9:14am | 344Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List today: Addus HomeCare Corp (ADUS) Amer Caresource Holdings (ANCI) Axcelis Tech Inc (ACLS) Carrizo Oil & Gas (CRZO) Carrols Restaurant Group (TAST) View the entire Zacks #5 Rank List. AXCELIS TECH (ACLS): Free Stock Analysis...
-
Deutsche Bank Raises PT On Quest Diagnostics To $64
Thursday, February 3, 2011 - 8:31am | 27Deutsche Bank has raised the price target on Quest Diagnostics (NYSE: DGX) from $59 to $64 and maintains its Hold rating.